Atovaquone

Wellvone 750 mg/5 ml suspensie voor oraal gebruik

Suspensie voor oraal gebruikNetherlandsAuthorisedAuthorised 24 Mar 1997

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Atovaquone

Wellvone 750 mg/5 ml suspensie voor oraal gebruik

Suspensie voor oraal gebruikNetherlandsAuthorisedAuthorised 24 Mar 1997

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Brazil · Zest Farmacêutica Ltda

Atovaquone GlenmarkItaly · Sospensione orale · Glenmark Pharmaceuticals S.R.O.

MepronUnited States · 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · tablet · Glaxosmithkline LLC

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Atovaquone
Dosage form: Suspensie voor oraal gebruik
Route: Oraal gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 24 Mar 1997
Registration: 21070
Marketing authorisation holder: GlaxoSmithKline B.V.
ATC code: P01AX06
Group: Antiparasitic products, insecticides and repellents
Procedure: National (RVG)
Supply: Uitsluitend recept